Molnupiravir Capsule shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Oct 20, 2026 · last update Oct 20, 2026
Manufacturers: Merck Sharp & Dohme LLC
Stated reasons (per FDA): Not stated (FDA did not give a reason)
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lagevrio, Capsule, 200 mg (NDC 0006-5055-06) | Merck Sharp & Dohme LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 20, 2026 Updated Oct 20, 2026 Discontinued Oct 20, 2026 |
| Lagevrio, Capsule, 200 mg (NDC 0006-5055-07) | Merck Sharp & Dohme LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 20, 2026 Updated Oct 20, 2026 Discontinued Oct 20, 2026 |
| Lagevrio, Capsule, 200 mg (NDC 0006-5055-09) | Merck Sharp & Dohme LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 20, 2026 Updated Oct 20, 2026 Discontinued Oct 20, 2026 |